These 5 low-cost, high-return MF schemes have gained over 60% in a year
When evaluating MF investments, prioritising high returns and minimising costs are crucial, where returns depend on investment growth in a specific period, and costs relate to the expenses incurred by investors in different schemes.
ETMarkets used the ETMutual Fund Screener to select five top-performing low-cost, high-return funds with returns surpassing 60% in a year. These funds maintained low expense ratios (below 1%) within their respective categories and garnered at least 4 ratings from Value Research. It's important to note that despite their strong performance, these funds carry a high-risk classification.
When evaluating MF investments, prioritising high returns and minimising costs are crucial, where returns depend on investment growth in a specific period, and costs relate to the expenses incurred by investors in different schemes.
Quant Infrastructure Fund Direct-Growth
Over the past 1 year, the fund has yielded a return of 73.89% whereas, Nifty Infrastructure returns for the same duration was 58.42%. Its current NAV stands at Rs 40.71 and its latest market value totals Rs 1636.43. The expense ratio of the fund is 0.77%.
ICICI Prudential BHARAT 22 FOF Direct - Growth
Over the past 1 year, the fund has yielded a return of 73.05% whereas, BSE Sensex returns for the same period was 20.42%. Its current NAV stands at Rs 29.82 and its latest market value totals Rs 733.04. The expense ratio of the fund is 0.08%.
Invesco India Infrastructure Fund Direct-Growth
Over the past 1 year, the fund has yielded a return of 66.31% whereas, Nifty Infrastructure returns for the same period was 58.42%. Its current NAV stands at Rs 62.80 and its latest market value totals Rs 856.76. The expense ratio of the fund is 0.85%.
SBI Healthcare Opportunities Fund Direct Plan-Growth
Over the past 1 year, the fund has yielded a return of 61.81% whereas, the BSE Healthcare Index returns for the same time duration was 61.83%. Its current NAV stands at Rs 392.20 and its latest market value totals Rs 2431.44. The expense ratio of the fund is 0.95%.
ADVERTISEMENT
Nippon India Pharma Fund Direct-Growth
Over the past 1 year, the fund has yielded a return of 61.65% whereas, the BSE Healthcare Index returns for the same time duration was 61.83%. Its current NAV stands at Rs 478.93 and its latest market value totals Rs 6891.31. The expense ratio of the fund is 0.95%. For further information regarding this screener, please click here
